ペプチドリームの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/05/27 | 4,700 | 4,865 | 4,685 | 4,840 | +180 | +3.9% | 902,500 |
2020/05/26 | 4,805 | 4,820 | 4,605 | 4,660 | -75 | -1.6% | 754,200 |
2020/05/25 | 4,645 | 4,740 | 4,615 | 4,735 | +185 | +4.1% | 723,900 |
2020/05/22 | 4,515 | 4,635 | 4,510 | 4,550 | +30 | +0.7% | 662,800 |
2020/05/21 | 4,540 | 4,620 | 4,485 | 4,520 | -25 | -0.6% | 743,900 |
2020/05/20 | 4,450 | 4,555 | 4,405 | 4,545 | +85 | +1.9% | 746,500 |
2020/05/19 | 4,390 | 4,475 | 4,330 | 4,460 | +95 | +2.2% | 731,500 |
2020/05/18 | 4,405 | 4,475 | 4,360 | 4,365 | ±0 | ±0% | 725,000 |
2020/05/15 | 4,240 | 4,395 | 4,180 | 4,365 | +55 | +1.3% | 733,900 |
2020/05/14 | 4,350 | 4,425 | 4,300 | 4,310 | -25 | -0.6% | 583,500 |
2020/05/13 | 4,280 | 4,370 | 4,260 | 4,335 | +85 | +2% | 654,700 |
2020/05/12 | 4,280 | 4,360 | 4,215 | 4,250 | -10 | -0.2% | 565,600 |
2020/05/11 | 4,295 | 4,325 | 4,195 | 4,260 | ±0 | ±0% | 621,900 |
2020/05/08 | 4,240 | 4,335 | 4,200 | 4,260 | +135 | +3.3% | 1,032,500 |
2020/05/07 | 3,940 | 4,145 | 3,925 | 4,125 | +145 | +3.6% | 711,100 |
2020/05/01 | 4,190 | 4,240 | 3,945 | 3,980 | -70 | -1.7% | 1,114,200 |
2020/04/30 | 4,060 | 4,090 | 3,995 | 4,050 | +45 | +1.1% | 772,100 |
2020/04/28 | 4,050 | 4,050 | 3,970 | 4,005 | +15 | +0.4% | 473,900 |
2020/04/27 | 3,930 | 4,055 | 3,910 | 3,990 | +85 | +2.2% | 526,300 |
2020/04/24 | 3,870 | 3,930 | 3,820 | 3,905 | +5 | +0.1% | 513,500 |
2020/04/23 | 3,970 | 3,975 | 3,855 | 3,900 | +25 | +0.6% | 523,700 |
2020/04/22 | 3,935 | 3,960 | 3,860 | 3,875 | -100 | -2.5% | 680,000 |
2020/04/21 | 3,850 | 4,015 | 3,815 | 3,975 | +145 | +3.8% | 1,051,300 |
2020/04/20 | 3,910 | 3,945 | 3,775 | 3,830 | -125 | -3.2% | 683,300 |
2020/04/17 | 3,925 | 3,985 | 3,860 | 3,955 | +125 | +3.3% | 1,090,200 |
2020/04/16 | 3,750 | 3,850 | 3,720 | 3,830 | +70 | +1.9% | 664,600 |
2020/04/15 | 3,730 | 3,840 | 3,675 | 3,760 | +170 | +4.7% | 943,100 |
2020/04/14 | 3,560 | 3,655 | 3,520 | 3,590 | +125 | +3.6% | 760,700 |
2020/04/13 | 3,330 | 3,485 | 3,310 | 3,465 | +95 | +2.8% | 567,500 |
2020/04/10 | 3,440 | 3,445 | 3,280 | 3,370 | -70 | -2% | 797,100 |
2020/04/09 | 3,395 | 3,455 | 3,340 | 3,440 | +45 | +1.3% | 738,700 |
2020/04/08 | 3,395 | 3,460 | 3,270 | 3,395 | -70 | -2% | 1,049,400 |
2020/04/07 | 3,305 | 3,475 | 3,305 | 3,465 | +200 | +6.1% | 1,082,200 |
2020/04/06 | 3,300 | 3,340 | 3,165 | 3,265 | -105 | -3.1% | 1,452,400 |
2020/04/03 | 3,500 | 3,560 | 3,350 | 3,370 | -140 | -4% | 776,100 |
2020/04/02 | 3,740 | 3,775 | 3,450 | 3,510 | -220 | -5.9% | 1,278,100 |
2020/04/01 | 3,735 | 3,845 | 3,660 | 3,730 | -40 | -1.1% | 695,200 |
2020/03/31 | 3,740 | 3,880 | 3,655 | 3,770 | +130 | +3.6% | 1,252,800 |
2020/03/30 | 3,800 | 3,840 | 3,585 | 3,640 | -305 | -7.7% | 1,667,300 |
2020/03/27 | 4,035 | 4,045 | 3,870 | 3,945 | +35 | +0.9% | 1,292,400 |
2020/03/26 | 3,940 | 4,025 | 3,880 | 3,910 | -145 | -3.6% | 1,218,200 |
2020/03/25 | 4,020 | 4,130 | 3,940 | 4,055 | +120 | +3% | 1,354,900 |
2020/03/24 | 4,015 | 4,070 | 3,895 | 3,935 | +35 | +0.9% | 1,319,100 |
2020/03/23 | 4,345 | 4,365 | 3,860 | 3,900 | -515 | -11.7% | 2,030,000 |
2020/03/19 | 4,585 | 4,780 | 4,355 | 4,415 | -125 | -2.8% | 1,812,300 |
2020/03/18 | 4,140 | 4,660 | 4,060 | 4,540 | +405 | +9.8% | 1,860,400 |
2020/03/17 | 3,710 | 4,200 | 3,680 | 4,135 | +360 | +9.5% | 2,060,700 |
2020/03/16 | 4,025 | 4,165 | 3,740 | 3,775 | -230 | -5.7% | 1,224,600 |
2020/03/13 | 3,715 | 4,030 | 3,605 | 4,005 | +10 | +0.3% | 1,384,600 |
2020/03/12 | 3,995 | 4,280 | 3,935 | 3,995 | -100 | -2.4% | 1,124,700 |
1201~
1250
件表示中 / 2899件
類似銘柄と比較する
現在ご覧いただいている「ペプチド」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ペプチド | 187,900円 | +5.0% | +1.5% | 0.00% | 16.13倍 | 4.29倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
日本新薬 | 358,900円 | +7.9% | +8.9% | 3.46% | 7.68倍 | 1.03倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
住友ファーマ | 62,300円 | +21.1% | - | 0.00% | 15.47倍 | 2.17倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
科研薬 | 415,900円 | +30.5% | +111.0% | 4.57% | 11.72倍 | 1.02倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
キッセイ薬 | 381,500円 | +14.5% | -2.3% | 2.36% | 13.96倍 | 0.75倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
市場注目の銘柄
チャート関連のコラム